Full-Time

Staff Engineer Intern

Site Reliability Engineering, Retail and Pharmacy

Deadline 10/31/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$118.5k - $260.6k/yr

+ Bonus + Commission + Short-term incentive + Equity award

Company Historically Provides H1B Sponsorship

Woonsocket, RI, USA

Hybrid

The posting indicates a remote/hybrid arrangement; the exact required on-site schedule is not stated.

Bachelor's

Category
Medical, Clinical & Veterinary (1)
Required Skills
LLM
Datadog
Kubernetes
Grafana
GitHub Actions
Apache Kafka
OpenTelemetry
Infrastructure as Code (IaC)
Istio
Prometheus
Terraform
Observability
Ansible
DevOps
Splunk

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • At least 8 years of experience in site reliability engineering, platform engineering, or production systems engineering with demonstrated program-level ownership.
  • End-to-end ownership of at least one major site reliability engineering program at organizational scale, such as an observability platform, production readiness framework, incident management operating model, or chaos engineering program.
  • Production or near-production experience designing and owning large language model integrations for operational use cases, including alert summarization, runbook generation, or incident triage acceleration.
  • Experience designing fleet-scale deployment reliability strategies, including progressive rollouts, blast radius budgeting, and configuration drift detection for large unattended node deployments; cloud-only reliability experience is insufficient.
  • Experience building cross-organizational adoption for new engineering standards in a large organization with established ways of working.
  • Ability to quantify site reliability engineering program return on investment in dollars, including incident cost reduction, toil hours eliminated, and engineer productivity recovered, and present the business case to stakeholders.
  • Technical Incident Commander certification or equivalent, with demonstrated leadership of P0/P1 incidents involving cross-organizational executive stakeholder coordination.
  • Deep observability platform expertise with at least two of Prometheus, Grafana, OpenTelemetry, Splunk, or Datadog.
  • Production-scale Apache Kafka streaming data platform experience.
  • Experience with analytical databases for observability workloads or equivalent columnar/time-series stores.
  • Experience with policy-as-code and CI/CD gate automation using OPA/Conftest, Checkov, or custom gate API design in enterprise pipelines.
  • Advanced Kubernetes expertise, including multi-cluster operations, edge k3s deployments, network policies, and workload failure mode analysis.
  • A Bachelor's degree in Computer Science, Engineering, or a related field, or equivalent practical experience.
Responsibilities
  • Architect the observability platform strategy end to end, including hot-tier event streaming, warm-tier analytical querying, cold-tier long-term storage, schema design, data contracts, and retention policy.
  • Define the organization-wide composite reliability signal framework, including aggregation of individual service-level indicators into domain health scores and fleet-wide reliability indicators mapped to business outcomes.
  • Drive service-level indicator and service-level objective standardization across engineering domains; own Critical User Journey coverage, gap analysis, business-impact severity mapping, and the roadmap to close gaps.
  • Design and own a production AI-enabled detection pipeline with time-series anomaly detection, large language model alert summarization, incident triage assistance, and feedback loops based on incident outcomes.
  • Design certificate and dependency lifecycle monitoring with automated discovery, alerting thresholds, ticket creation, an SRE approval gate, and closed-loop renewal validation.
  • Evaluate and adopt observability standards including OpenTelemetry and eBPF-based tooling for low-overhead infrastructure observability.
  • Design connectivity-tolerant telemetry collection, local buffering, and fleet-aggregated health signals for unattended edge nodes with intermittent connectivity.
  • Own the Production Readiness Review framework, including principles, checklists, YAML-based manifests or equivalent, and automated policy enforcement through OPA/Conftest, GitHub Actions gates, or custom CI/CD SRE review APIs.
  • Design and run the organizational chaos engineering and GameDay program, including steady-state hypotheses, failure-injection scenarios, multi-domain exercises, and readiness measurement.
  • Lead fleet-scale deployment reliability by designing progressive rollouts, canary cohorts, staged fleet expansion, geographic blast-radius budgets, deployment gates, and rollback service-level agreements.
  • Design configuration drift detection systems with proactive alerting and automated or semi-automated remediation paths.
  • Lead hardware and infrastructure risk assessments for major platform programs, including compute sizing, memory constraints, and runtime isolation requirements.
  • Define change-management reliability gates, including change-review standards, rollback service-level agreements, deployment freeze windows, and blast-radius assessment criteria.
  • Partner with architecture review boards to embed reliability non-functional requirements into major platform designs.
  • Design and operationalize a tiered incident response model with severity tiers, service and fleet criticality classifications, and proactive monitoring cohorts.
  • Serve as a certified Technical Incident Commander and lead P0/P1 incident bridges across Engineering, Infrastructure, Operations, and executive leadership.
  • Own the on-call operating model, including shift structure, follow-the-sun coverage, domain-assigned ownership tiers, coverage-gap analysis, escalation service-level agreements, and quarterly on-call health reviews.
  • Design alert-management and suppression governance, including maintenance and deployment suppression policies, alert routing rules, and severity promotion or demotion criteria.
  • Own the mean time to resolution reduction program, establishing the within-service-level-agreement baseline and improving runbooks, automation, and escalation paths.
  • Own the postmortem program, including causal taxonomy, quality scoring, facilitation framework, and review cadence across incident types and severity levels.
  • Design the three-phase incident learning model using structured operational records, AI-assisted transcription and timeline reconstruction, Technical Incident Commander root-cause analysis, and blameless postmortems.
  • Engineer the incident-learning feedback loop as a data pipeline from incident data through causal classification, Production Readiness Review updates, engineering practice changes, and recurrence reduction.
  • Measure learning velocity as the time from first occurrence of an incident class to systemic resolution.
  • Partner with Problem Management to align postmortem standards, systemic issue escalation criteria, and cross-organizational incident-learning governance.
  • Own P1/P2 trend analysis, quantify business impact, and build investment cases for programs that reduce repeat incidents.
  • Own the Site Reliability Engineering Developer Platform, including onboarding kits, observability integration templates, developer-facing reliability APIs, and self-service service-level objective health pages.
  • Define the organization-wide DORA metrics program, establish baselines for Deployment Frequency, Lead Time for Change, Mean Time to Resolution, and Change Failure Rate, and report monthly to engineering leadership.
  • Drive self-service reliability adoption through developer-owned service-level objective dashboards, automated Production Readiness Review manifests, and service health pages.
  • Evangelize the reliability covenant across engineering domain owners and transfer reliability capability to engineering teams.
  • Quantify and report organizational toil economics, including manual operational touchpoints, automation coverage, and capacity recovered through toil elimination.
  • Build organizational buy-in for reliability programs before broad adoption.
  • Develop and execute adoption strategies for each major program by delivering a minimum viable version, measuring outcomes, and expanding adoption.
  • Diagnose organizational resistance to program adoption and adapt the approach based on value, timing, friction, and competing priorities.
  • Establish relationships with engineering domain owners as a peer and understand their delivery pressures and reliability investment needs.
  • Represent Site Reliability Engineering at the engineering leadership level by communicating program health, reliability trends, investment priorities, and return on investment to directors and vice presidents.
Desired Qualifications
  • Experience architecting observability data platforms with hot-, warm-, and cold-storage tiers and analyzing schema-on-read versus schema-on-write trade-offs.
  • Experience designing organizational chaos engineering programs, including GameDay hypothesis libraries and multi-domain facilitation using LitmusChaos, Chaos Monkey, or Chaos Toolkit.
  • AIOps implementation experience, including production time-series anomaly detection, LLM-assisted operational tooling, or machine-learning-driven alert correlation at scale.
  • Program-scale infrastructure-as-code experience with Terraform, Pulumi, or Ansible for fleet-level reliability infrastructure.
  • Production-scale service mesh architecture and operations using Istio, Envoy proxy, or Linkerd, including circuit breakers, retries, and traffic shaping.
  • Experience operating systems in retail, pharmacy, healthcare, or similarly regulated and operationally sensitive environments.
  • Experience with edge-computing fleet operations, including Kubernetes distributions at store or device scale, SSR/SD-WAN networking, and hybrid cloud-edge reliability patterns.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
  • CVS and Eli Lilly launch Zepbound and Foundayo pricing in-app by early Q4 2026.
  • CVS opened pharmacy-focused Houston stores and plans nearly 20 nationwide openings.

What critics are saying

  • Reuters said Caremark expects weaker client retention after August 5, 2026 results.
  • Louisiana settled three PBM lawsuits with CVS for $45 million on February 20, 2026.
  • Tennessee's FAIR Rx Act threatens 137 CVS pharmacies and MinuteClinics, risking forced divestiture.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies across U.S. scale.
  • August 5, 2026 results showed all three segments beat revenue expectations.
  • Teresa Heitsenrether joins the board November 18, 2026, signaling data-driven healthcare execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

Yahoo Finance
Aug 11th, 2026
AbbVie acquires Apogee Therapeutics for $10.9B amid pipeline expansion

AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.

Yahoo Finance
Aug 5th, 2026
CVS Health Q2 earnings beat expectations, partners with Eli Lilly on weight loss drugs

CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.